Prescription drugs : implications of drug labeling and off-label use : statement of Sarah F. Jagger, Director of Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U.S. House of Representatives /

Bibliographic Details
Main Author:	Jagger, Sarah F.
Corporate Authors:	United States. General Accounting Office, United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations
Format:	Government Document Book
Language:	English
Published:	Washington, D.C. : The Office ; [1996]
Series:	Testimony ; GAO/T-HEHS-96-212.
Subjects:	Drugs > Labeling > United States. Drugs > Prescribing > United States. Drugs > United States > Generic substitution. Generic drugs > United States.
Online Access:	Adobe Acrobat Reader required

Description
Item Description:	Not distributed to depository libraries in a physical form. "September 12, 1996."
Physical Description:	8 pages ; 28 cm. Available via Internet from the GPO Access web site. Address as of 5/21/2001: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:he96212t.pdf; current access is available via PURL.
Bibliography:	Includes bibliographical references.